LSP-Life Sciences Partners has had 12 exits in the past 18 months, almost the same number as in 2006-11. Sources: LSP; BCIQ: BioCentury Online Intelligence

Company

Business

Exit

Deal value

Exit date

Activaero GmbH

Respiratory compounds based on its nebulization- based drug delivery technology

Acquired by Vectura Group plc (LSE:VEC)

€130M ($180.6M) comprising €95M ($132M) in cash and stock and €35M ($48.6M) in a deferred cash payment; also up to €6M ($8.3M) tied to future deals involving Activaero's technologies

Mar-14